Skip to main content

Table 2 Feasibility criteria and completion rate according to each step of the trial. The results are presented according to each feasibility criterion (per treatment)

From: Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma

 

Target

Range

Delivered

Median (range)

STEP 01 (5 unresectable patients)

 Radiotherapy dose

49.5–55 Gy

55 Gy (55)

 Cisplatin dosage (mg/m2)

105–140

140 (105–140)

 Overall treatment time (days)

< 35

29 (29–30)

STEP 02 (step 01 + 5 patients) Resectable or unresectable

 Radiotherapy dose

50–55 Gy

55 (55)

 Cisplatin dosage (mg/m2)

105–140

140 (70–140)

 Overall treatment time (days)

< 35

29 (27–34)

STEP 03 (step 2 + 10 patients) Resectable or unresectable

 Radiotherapy dose

50–55 Gy

55 (55)

 Cisplatin dosage (mg/m2)

105–140

122 (70–140)

 Overall treatment time (days)

< 35

29 (27–34)